Cargando…
Sequential Combination of a Strong Interferon Inducer Viral Vector With Low Doses of Nivolumab Plus Ipilimumab Could Provide Functional Cure in Chronic Hepatitis B Virus infections: Technical Report Proposing a New Modality
Based on the recommendation of the International Coalition to Eliminate hepatitis B virus (ICE-HBV), we intend to mimic the spontaneous resolution of HBV infection to achieve a functional cure of chronic hepatitis B virus (HBV) infection. To this end, we propose sequential targeting of the innate an...
Autores principales: | Bakacs, Tibor, Safadi, Rifaat, Puskás, László G, Fehér, Liliána Z, Kovesdi, Imre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970536/ https://www.ncbi.nlm.nih.gov/pubmed/35371882 http://dx.doi.org/10.7759/cureus.22750 |
Ejemplares similares
-
Post-infection viral superinfection technology could treat HBV and HCV patients with unmet needs
por: Bakacs, Tibor, et al.
Publicado: (2018) -
An Orally Administered Nonpathogenic Attenuated Vaccine Virus Can Be Used to Control SARS-CoV-2 Infection: A Complementary Plan B to COVID-19 Vaccination
por: Bakacs, Tibor, et al.
Publicado: (2022) -
Complete Remission of Vocal Cord Cancer Treated With Low-Dose Ipilimumab Plus Nivolumab Combined With Interleukin-2 and Hyperthermia
por: Kleef, Ralf, et al.
Publicado: (2021) -
Editorial: Fighting fire with fire: Using non-pathogenic viruses to control unrelated infections
por: Bakacs, Tibor, et al.
Publicado: (2022) -
Multiorgan Failure From Nivolumab and Ipilimumab: A Case Report and Literature Review
por: Brazel, Danielle, et al.
Publicado: (2023)